Neurotez

Neurotez

Innovative Solutions for Brain Disorders

Security Type
Common Stock
Industry
Medical
Min Investment
$496
Location
Bridgewater, NJ
Offering Date
November 09, 2021
Expected Close Date
February 09, 2022
Amount Raised
$24,956
Security Price
$4

Key Deal Facts

Currently there is an FDA approved drug on the market, but despite the limited evidence for its efficacy, it's available for $56,000 per patient per year - creating a $366 billion market in the US alone.
Drug as a biologic will get 12 years of market exclusivity from the US.
Data from pre-clinical studies demonstrating efficacy as a disease modification entity.

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments